5-Flucytosine

This page contains recent news articles, when available, and an overview of 5-Flucytosine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

5-Flucytosine
(when available)

Pharmacology and use:
Flucytosine is an antimetabolite that acts as an antifungal agent with in vitro and in vivo activity against Candida and Cryptococcus. Flucytosine enters the fungal cell via cytosine permease; whereupon it is metabolized to 5-fluorouracil within fungal organisms. The 5-fluorouracil is extensively incorporated into fungal RNA and inhibits synthesis of both DNA and Antifungal synergism between Ancobon and polyene antibiotics, particularly amphotericin B, has been reported. For treatment of (in combination with Amphotericin B) meningitis, endophthalmitis and pylelonephritis

Mechanism Of Action:
Although the exact mode of action is unknown, it has been proposed that flucytosine acts directly on fungal organisms by competitive inhibition of purine and pyrimidine uptake and indirectly by intracellular metabolism to monophosphate, a noncompetitive inhibitor of the fungal thymidylate synthetase which interferes with DNA synthesis. Flucytosine interrupts nucleic acid and protein synthesis. The cells of the host do not convert large quantities of flucytosine to fluorouracil, accounting for the selective toxicity of the compound against fungi.

News Articles on 5-Flucytosine

FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for ...  -  ‎Jul 7, 2009‎
YO-2V), which contains the four most widely-prescribed antifungals: itraconazole, fluconazole, 5 flucytosine and voriconazole. PR Newswire (press release)

Brand Names/Synonyms:
5-Flucytosine is also known by the following brand names and/or synonyms:
Ancobon; Ancotil; Flucytosin; Flucytosine; Fluocytosine; Fluorcytosine

Drug Category:
5-Flucytosine is categorized under the following by the FDA: Antimetabolites; Antifungals; ATC:D01AE21; ATC:J02AX01

Dosage Forms:
Not Available

Absorption:
Rapidly and completely absorbed, bioavailability is 78-90%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
4-amino-5-fluoro-3H-pyrimidin-2-one





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy